Healthcare was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring... their HIV assets to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
and communities. ViiV Healthcare was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies... by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi. Are you energized by a highly visible role within the managed markets...
on individuals and communities. ViiV Healthcare was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009... is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi. Are you looking for a new challenge in a critical strategic...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
Healthcare was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring... their HIV assets to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the imm...
Territory to include, but not limited to: Winchester, VA Role Overview: For more than 140 years, GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio of more t...
Business Introduction We make and supply medicines and vaccines all around the globe and our teams own every production stage, from creating quality products at our manufacturing sites to designing effective supply forecasting and regulat...
Scientist, Oligo Discovery Biology At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, c...
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the imm...